Stay updated on Adagrasib in Elderly/Poor Performance KRASG12C NSCLC Clinical Trial
Sign up to get notified when there's something new on the Adagrasib in Elderly/Poor Performance KRASG12C NSCLC Clinical Trial page.

Latest updates to the Adagrasib in Elderly/Poor Performance KRASG12C NSCLC Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe record history now reflects a new revision tag, v3.6.4, replacing the previous v3.6.3.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedAdded a new revision entry (v3.6.3) and removed the prior revision (v3.6.2) in the record history. This updates the visible version tag without changing the underlying study content or status.SummaryDifference0.1%

- Check42 days agoChange Detected2026-06-22 adds Study Status and Contacts/Locations to the record history and updates the revision to v3.6.2. The previous revision v3.6.0 from 2026-04-27 is removed.SummaryDifference0.5%

- Check57 days agoChange DetectedThe history now includes a recruitment status change to 'No longer looking for participants'. It also shows the addition of Revision: v3.6.0 and removal of Revision: v3.5.5.SummaryDifference0.3%

- Check64 days agoChange DetectedThe history now shows Revision: v3.5.5, superseding v3.5.4, indicating a new revision of the record was saved. This appears to be a routine version update and does not reflect changes to the study details or results.SummaryDifference0.1%

- Check85 days agoChange DetectedThe page now displays the revision tag as v3.5.4 in the footer, replacing the previous v3.5.3 and signaling a refreshed version of the record history. This update reflects a metadata version change rather than substantive content changes.SummaryDifference0.1%

Stay in the know with updates to Adagrasib in Elderly/Poor Performance KRASG12C NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Adagrasib in Elderly/Poor Performance KRASG12C NSCLC Clinical Trial page.